August 31-September 2, 2016 Munich/Germany
AXON Neuroscience SE
Bratislava/SK
DZNE - Deutsches Zentrum für Neurodegenerative Erkrankungen e.V.
Helmholtz Virtuelles Institut (VI-510) "RNA dysmetabolism in ALS and FTD"
Pfizer Pharma GmbH
Berlin
UCB BioPharma sprl
Brussels/BE
Proteintech Europe Limited
Manchester/GB
Actelion
Freiburg/DE
Quanterix Corporation
Lexington, MA/US
The International Centre for Genetic Engineering and Biotechnology (ICGEB)
Trieste/IT
German Research Foundation (DFG)
Bonn